Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization (Q45388085)

14 December 2017

title

Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization (English)

1 reference

14 December 2017

1 reference

Isabelle Rouiller

6

0 references

author name string

Jafar Kafaie

1

1 reference

14 December 2017

Marjan Dolatshahi

2

1 reference

14 December 2017

Lara Ajamian

3

1 reference

14 December 2017

Rujun Song

4

1 reference

14 December 2017

Andrew J Mouland

5

1 reference

14 December 2017

Michael Laughrea

7

1 reference

14 December 2017

language of work or name

English

0 references

publication date

13 December 2008

1 reference

14 December 2017

number of pages

12

1 reference

inferred from page(s)

published in

Virology

1 reference

14 December 2017

volume

385

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

233-244

1 reference

Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Nucleotide excision repair and template-independent addition by HIV-1 reverse transcriptase in the presence of nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Structural organization of authentic, mature HIV-1 virions and cores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

The stoichiometry of Gag protein in HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Mutations in HIV reverse transcriptase which alter RNase H activity and decrease strand transfer efficiency are suppressed by HIV nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Context-dependent phenotype of a human immunodeficiency virus type 1 nucleocapsid mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Rapid kinetics of protein-nucleic acid interaction is a major component of HIV-1 nucleocapsid protein's nucleic acid chaperone function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

The structure and function of the aspartic proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Cryo-electron microscopy of vitrified specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Structure of full-length HIV-1 CA: a model for the mature capsid lattice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Functional inactivation of genes by dominant negative mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Kissing-loop model of HIV-1 genome dimerization: HIV-1 RNAs can assume alternative dimeric forms, and all sequences upstream or downstream of hairpin 248-271 are dispensable for dimer formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Involvement of HIV-I nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

The effect of cell division on the cellular dynamics of microinjected DNA and dextran

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Transmission electron microscopy reveals an optimal HIV-1 nucleocapsid aggregation with single-stranded nucleic acids and the mature HIV-1 nucleocapsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Suboptimal inhibition of protease activity in human immunodeficiency virus type 1: effects on virion morphogenesis and RNA maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

High-resolution structure of a retroviral capsid hexameric amino-terminal domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Replacement of the P1 amino acid of human immunodeficiency virus type 1 Gag processing sites can inhibit or enhance the rate of cleavage by the viral protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Three-dimensional structures of HIV-1 and SIV protease product complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

HIV-1 viral RNA is selected in the form of monomers that dimerize in a three-step protease-dependent process; the DIS of stem-loop 1 initiates viral RNA dimerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Role of the 5' TAR stem--loop and the U5-AUG duplex in dimerization of HIV-1 genomic RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Nucleocapsid protein function in early infection processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Transfection by cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Intracellular trafficking of plasmids for gene therapy: mechanisms of cytoplasmic movement and nuclear import

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Immunological and chemical analysis of P6, the carboxyl-terminal fragment of HIV P15.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

RNA incorporation is critical for retroviral particle integrity after cell membrane assembly of Gag complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Nucleocapsid-RNA interactions are essential to structural stability but not to assembly of retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

7 January 2021

Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

7 January 2021

Functional domains of the capsid protein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

7 January 2021

Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

7 January 2021

An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

7 January 2021

Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

7 January 2021

Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.11.028

7 January 2021

10.1016/J.VIROL.2008.11.028

Identifiers

DOI

1 reference

release_2r3hqaptvzgmtnq53z532yfaoi

14 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2r3hqaptvzgmtnq53z532yfaoi

24 November 2022

mapped directly with Wikidata item

1 reference